Financials
- Market Capitalization 25.91 M
- Employee 44
- Founded 2010
- CEO N/A
- Website www.beyondspringpharma.com
- Headquarter New Jersey, United States
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
8.58
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4479 | NNVC NanoViricides, Inc. Common Stock | 1.25 USD | -3.10% | -6.72% | -21.38% | +23.75% | 27.06 M USD | ||
| 4481 | LTRN Lantern Pharma Inc. - Common Stock | 2.10 USD | -2.78% | -9.87% | -18.60% | -49.88% | 26.85 M USD | ||
| 4495 | EVAX Evaxion A/S - American Depositary Share | 3.06 USD | -2.86% | -8.93% | +8.90% | -7.83% | 25.52 M USD | ||
| 4501 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.51 USD | -4.92% | -1.57% | +5.91% | +225.97% | 25.05 M USD |